Literature DB >> 4366990

Antibodies to herpes group viruses in patients with nasopharyngeal and other head and neck cancers.

B E Henderson, E Louie, E Bogdanoff, W Henie, B Alena, G Henie.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4366990

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  6 in total

Review 1.  Relationship between antibody production to Epstein-Barr virus (EBV) early antigens and various EBV-related diseases.

Authors:  T Ooka; M de Turenne-Tessier; M C Stolzenberg
Journal:  Springer Semin Immunopathol       Date:  1991

2.  A high incidence of serum IgG antibodies to the Epstein-Barr virus replication activator protein in nasopharyngeal carcinoma.

Authors:  A Mathew; H M Cheng; C K Sam; I Joab; U Prasad; C Cochet
Journal:  Cancer Immunol Immunother       Date:  1994-01       Impact factor: 6.968

3.  An areawide cancer reporting network.

Authors:  J C Hisserich; S P Martin; B E Henderson
Journal:  Public Health Rep       Date:  1975 Jan-Feb       Impact factor: 2.792

4.  Epstein-Barr virus antibody patterns preceding the diagnosis of nasopharyngeal carcinoma.

Authors:  C K Chan; N Mueller; A Evans; N L Harris; G W Comstock; E Jellum; K Magnus; N Orentreich; B F Polk; J Vogelman
Journal:  Cancer Causes Control       Date:  1991-03       Impact factor: 2.506

Review 5.  Overview of immunology of oral squamous cell carcinoma.

Authors:  Anisha Cynthia Sathiyasekar; Pavithra Chandrasekar; Arul Pakash; K U Goma Kumar; M S Jaishlal
Journal:  J Pharm Bioallied Sci       Date:  2016-10

6.  Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma.

Authors:  H C Ho; M H Ng; H C Kwan; J C Chau
Journal:  Br J Cancer       Date:  1976-12       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.